Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
through cutting-edge research. The Department of Diabetes and Cancer Metabolism at City of Hope is seeking a highly motivated Postdoctoral Fellow in Computational Biology/Bioinformatics to join an NIH R01
-
, shaping the future of medicine through cutting-edge research. We are looking for a Staff Scientist for the Computational Data Sciences Shared Resource. You will provide advanced analytical, computational
-
in computational cancer biology. Our lab aims to enhance cancer treatment outcomes through two main research areas: Investigating the biological mechanisms underlying tumor progression: We use single
-
should include: · Master’s Degree or Ph.D. Degree in Bioinformatics, Computer Science, Mathematics, Statistics. Equivalent Experience preferred. · 3+ years of relevant experience in
-
methodology and database computing. Lead or collaborate on research and development projects that apply statistical and computing methods to medical and biological research. Support research design, quality
-
through cutting-edge research. The Nath Laboratory is seeking highly motivated applicants for a postdoctoral position in computational oncology and data science. Our research program aims to advance
-
of the Principal Investigator, or designee, you will perform assays to support research studies, assist in the interpretation of research outcomes, analyze data using computer-based approaches, train new staff
-
the supervision of a Ph.D.-level biostatistician. Program statistical analyses using statistical software packages and connect statistical methods to medical or biological research questions. Collaborate with
-
interdisciplinary academic community. As a successful candidate, you will: Establish and direct a rigorous research program that addresses significant questions in your field of expertise. Disseminate findings
-
talented scientists for two postdoctoral scholar positions. Our interdisciplinary research program focuses on developing prophylactic and therapeutic vaccines and immunotherapies against oncogenic gamma